Gene regulatory biomarker identification for skin toxicities induced by EGFR inhibitor treatment

Int J Clin Pharmacol Ther. 2015 Dec;53(12):1056-8. doi: 10.5414/CPXCES14EA08.

Abstract

1 Federal Institute for Drugs and Medical Devices (BfArM), Research Division, Bonn, 2 Institute of Pharmacology of Natural Products and Clinical Pharmacology, 3 Department of Internal Medicine II, University of Ulm, Ulm, 4 Pneumology, Thoracic Oncology, Sleep- and Respiratory Critical Care Medicine, Clinics Kempten-Oberallgäu, Kempten, and 5 Department of Internal Medicine I, University of Ulm, Ulm, and 4 Department of Internal Medicine I, Martin Luther University Halle-Wittenberg, Germany.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / analysis
  • ErbB Receptors / antagonists & inhibitors*
  • Humans
  • MicroRNAs / physiology
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Pharmacogenetics
  • Skin / drug effects*

Substances

  • Biomarkers
  • MicroRNAs
  • ErbB Receptors